Patients Receiving Chemotherapy May Not be at Increased Risk for COVID-19
Study shows disruptions to cancer treatment could be minimized during the pandemic PHILADELPHIA – Compared with patients with cancer...
Search/Filter
Loading...
Patients With Lymphoma Treated With B-cell-depleting Therapies May Have Worse Outcomes From COVID-19 Infection
PHILADELPHIA – Among patients with lymphoma admitted to the hospital for severe COVID-19, those treated with B-cell-depleting therapies within...
Drive-by FluFIT Clinics May Increase Colorectal Cancer Screening Rates During the COVID-19 Pandemic
PHILADELPHIA – Administering colorectal cancer screening kits through a socially distant drive-by flu vaccination clinic increased access to colorectal...
Circulating Tumor Cell Dynamics May Predict Treatment Response and Prognosis in Patients with Metastatic Breast Cancer
SAN ANTONIO – Early circulating tumor cell dynamics were associated with overall survival in patients with metastatic breast cancer,...
Under-recognition of Symptoms May Be Common in Patients With Breast Cancer Receiving Radiotherapy
Symptom under-recognition may be more common among younger patients and Black patients SAN ANTONIO – Among patients with breast...
Women Who Undergo Mastectomy and Reconstructive Surgery May Be at Risk of Becoming Persistent Drug Users
SAN ANTONIO – Women who receive mastectomy and reconstructive surgery as part of breast cancer treatment may face the...
Postmenopausal Women With Early-stage Breast Cancer and Low Recurrence Score Could Skip Adjuvant Chemotherapy
Adjuvant chemotherapy may yield improved survival outcomes for premenopausal counterparts SAN ANTONIO – After a median follow-up of 5.1...
Omitting Radiation Therapy After Breast-Conserving Surgery May Not Impact 10-year Survival Rates for Older Patients With HR-positive Breast Cancer
SAN ANTONIO – Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery...
Breast Cancer Survivors Are Less Likely to Get Pregnant, but Often Have Healthy Babies and Good Long-term Health
SAN ANTONIO – A large meta-analysis of breast cancer survivors of childbearing age indicated that they are less likely...
Updated monarchE Trial Data Shows Abemaciclib Continues to Benefit Patients With High-risk, HR-positive, HER2-negative, Early-stage Breast Cancer
SAN ANTONIO – Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK)...